ChemDiv to Supply Italien Nerviano Medical Sciences with Discovery Chemical Libraries
"Our business relationship with ChemDiv is entering a phase of joint scientific endeavours with ambitious goals of innovation. The strengths of High-Throughput Screening and Combinatorial Chemistry at NervianoMS shall be complemented with ChemDiv's fully aligned synthetic productivity. NervianoMS is a world leader in oncology-focused R&D and one of a handful that performs HTS with a throughput of millions of data points per year. It is also one of only a couple in the world that conducts HTS campaigns running assays in parallel. Useful new chemical entities will be generated and tested with an efficiency level of the highest standard", said Francesco Colotta, VP of Oncology , NervianoMS.
"Collaboration with NervianoMS, a leader in area of oncology-focused drug discovery and development, further expands our capabilities to elaborate and accomplish custom synthesis projects to fulfill all requirements of our partners. Our alliance with Nerviano has already produced very promising results and we expect it to strengthen our competitive position," said Alexander Kiselyov, Executive VP of Research & Development, ChemDiv.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.